Intermountain Ventures

– Saama technologies announced a strategic growth investment and will be acquired by Carlyle.
– Saama’s intelligent Life Science Analytics Cloud (LSAC) is used by over 50 pharma and biotech companies on more than 1,500 studies.
– As an end-to-end platform, LSAC provides a unified approach to clinical trial data management and analytics.
– Carlyle has made a strategic growth investment and will acquire a majority stake in the Company.
– A broad co-investor group with several healthcare-focused venture funds, including Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund, McKesson Ventures, Northpond Ventures, Pfizer Ventures, and Population Health Partners, will be investing alongside Carlyle.

– Axuall, a digital professional identity network that enables healthcare providers to share their authenticated credentials and qualifications in real-time, announced that they closed $10.4m in Series A funding led by Flare Capital Partners.
– The round was led by Flare Capital Partners and includes participation from the company’s executive leadership, Intermountain Ventures, University Hospitals Ventures, MedStar Health, Epsilon Health, InHealth Ventures, AV8 Ventures, JumpStart, M25 Ventures, and North Coast Ventures.
– Capital from this financing will be used to accelerate R&D, implementations, sales, and marketing as the company grows its customer base of healthcare organizations.
– “Led by Flare Capital Partners and representing over two dozen healthcare organizations, this financing represents a ringing endorsement from the healthcare community,” said Axuall’s CEO, Charlie Lougheed.